Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes Academic Article uri icon

Overview

MeSH Major

  • Gene Expression Regulation, Neoplastic
  • Glioblastoma
  • Mutation
  • Receptor, Epidermal Growth Factor

abstract

  • The overall survival of patients with thalamic glioblastoma is comparable to unresectable lobar supratentorial GBMs. Younger patients and those with good presenting functional status had improved survival. Midbrain involvement by the tumor is not a negative prognostic factor. Improved therapies are needed, and patients should be considered for early trial involvement and aggressive upfront therapy.

publication date

  • July 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/neuros/nyx349

PubMed ID

  • 28973417

Additional Document Info

start page

  • 76

end page

  • 85

volume

  • 83

number

  • 1